...
首页> 外文期刊>Journal of pain & palliative care pharmacotherapy >Dexmedetomidine: a novel analgesic with palliative medicine potential.
【24h】

Dexmedetomidine: a novel analgesic with palliative medicine potential.

机译:右美托咪定:一种具有姑息治疗潜力的新型镇痛药。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Dexmedetomidine has gained popularity in anesthesia and critical care for use in deep sedation and analgesia due to a combination of its efficacy and safety compared with other available agents (e.g., opioids, benzodiazepines, propofol) conventionally used in these settings. This brief review is meant to introduce this unique agent to the palliative care field, as dexmedetomidine may hold promise for patients in hospice and palliative care settings whose symptoms are refractory to usual therapies. [Be sure to be clear in the abstract that more studies are warranted and its role is not well defined and is complicated by significant drug interactions, invasive i.v. route and has a significant side effect profile.]
机译:右美托咪定由于其功效和安全性与常规用于这些场合的其他可用药物(例如阿片类药物,苯二氮卓类,丙泊酚)相结合,已在麻醉和重症监护镇痛中得到广泛应用。这篇简短的综述旨在将这种独特的药物介绍到姑息治疗领域,因为右美托咪定可能为那些临终治疗难以治愈的临终和姑息治疗患者提供希望。 [请务必在摘要中明确指出,有必要进行更多的研究,并且其作用尚不明确,并且会因药物相互作用(侵入性静脉内注射)而变得复杂。途径,并且有明显的副作用。]

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号